A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
10.1007/s11657-013-0116-9 99
doi: 10.3389/fpsyt.2024.1347178 Received 30 November 2023 Accepted 24 January 2024 Published 13 February 2024 Volume 15 - 2024 Edited by David Cohen, Sorbonne Universits, France Reviewed by Magdalena Sowa-Kucma, University of Rzeszow, Poland Iva Dudova, Charles University, Czechia Updates Copyright 2024 Ilavsk, Morvov, Paduchov, Muchov, Garaiova, urakov, ikurov and Trebatick
Aggregated panel responses formed the basis of the final recommendations, which are intended to provide clinicians an experience-driven guidance for practical application
1:5000 in WB), HA-tag mouse monoclonal antibody (Santa Cruz
However, both are potent anti-oxidants and participate in reducing oxidative stress in the body